Your browser doesn't support javascript.
Inflammatory responses in SARS-CoV-2 associated Multisystem Inflammatory Syndrome and Kawasaki Disease in children: An observational study.
Biesbroek, G; Kapitein, B; Kuipers, I M; Gruppen, M P; van Stijn, D; Peros, T E; van Veenendaal, M; Jansen, M H A; van der Zee, C W; van der Kuip, M; von Asmuth, E G J; Mooij, M G; den Boer, M E J; Landman, G W; van Houten, M A; Schonenberg-Meinema, D; Tutu van Furth, A M; Boele van Hensbroek, M; Scherpbier, H; van Meijgaarden, K E; Ottenhoff, T H M; Joosten, S A; Ketharanathan, N; Blink, M; Brackel, C L H; Zaaijer, H L; Hombrink, P; van den Berg, J M; Buddingh, E P; Kuijpers, T W.
  • Biesbroek G; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • Kapitein B; Pediatric Intensive Care Unit, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • Kuipers IM; Pediatric Cardiology, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • Gruppen MP; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • van Stijn D; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • Peros TE; Pediatric Intensive Care Unit, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • van Veenendaal M; Department of Pediatric Immunology and Infectious Disease, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Jansen MHA; Department of Pediatric Immunology and Infectious Disease, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van der Zee CW; Department of Pediatrics, Hilversum, The Netherlands.
  • van der Kuip M; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • von Asmuth EGJ; Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
  • Mooij MG; Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
  • den Boer MEJ; Department of Pediatrics, Medical Spectrum Twente, Enschede, The Netherlands.
  • Landman GW; Department of Internal medicine, Gelre Hospital, Apeldoorn, The Netherlands.
  • van Houten MA; Department of Pediatrics, Spaarne Hospital, Haarlem, The Netherlands.
  • Schonenberg-Meinema D; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • Tutu van Furth AM; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • Boele van Hensbroek M; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • Scherpbier H; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • van Meijgaarden KE; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Ottenhoff THM; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Joosten SA; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Ketharanathan N; Department of Pediatric Surgery and Intensive Care, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Blink M; Pediatric Intensive Care Unit, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
  • Brackel CLH; Department of Pediatrics, Hilversum, The Netherlands.
  • Zaaijer HL; Department of Pediatric Pulmonology, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • Hombrink P; Department of Virology, Sanquin Research Institute, University of Amsterdam, Amsterdam, The Netherlands.
  • van den Berg JM; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam, Amsterdam, The Netherlands.
  • Buddingh EP; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • Kuijpers TW; Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
PLoS One ; 17(11): e0266336, 2022.
Article in English | MEDLINE | ID: covidwho-2140381
ABSTRACT
Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe inflammatory disease in children related to SARS-CoV-2 with multisystem involvement including marked cardiac dysfunction and clinical symptoms that can resemble Kawasaki Disease (KD). We hypothesized that MIS-C and KD might have commonalities as well as unique inflammatory responses and studied these responses in both diseases. In total, fourteen children with MIS-C (n=8) and KD (n=6) were included in the period of March-June 2020. Clinical and routine blood parameters, cardiac follow-up, SARS-CoV-2-specific antibodies and CD4+ T-cell responses, and cytokine-profiles were determined in both groups. In contrast to KD patients, all MIS-C patients had positive Spike protein-specific CD3+CD4+ T-cell responses. MIS-C and KD patients displayed marked hyper-inflammation with high expression of serum cytokines, including the drug-targetable interleukin (IL)-6 and IFN-γ associated chemokines CXCL9, 10 and 11, which decreased at follow-up. No statistical differences were observed between groups. Clinical outcomes were all favourable without cardiac sequelae at 6 months follow-up. In conclusion, MIS-C and KD-patients both displayed cytokine-associated hyper-inflammation with several high levels of drug-targetable cytokines.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Connective Tissue Diseases / COVID-19 / Mucocutaneous Lymph Node Syndrome Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Child / Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0266336

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Connective Tissue Diseases / COVID-19 / Mucocutaneous Lymph Node Syndrome Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Child / Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0266336